Biotechnologia medyczna: czy zostanie wizytówką polskiej innowacji? Marta Winiarska, prezes BioInMed

🎙 Medical biotechnology – will it become a showcase for Polish innovation? In this episode, we speak with Marta Winiarska, president of the Polish Association of Innovative Medical Biotechnology Companies BioInMed, an organization supporting the development of innovative therapies and technologies in medicine. In the MamBiznes: Startup Talks podcast, she discusses the path from idea to implementation of a new drug and the biggest challenges in this industry in Poland and globally. 🔬 We cover: What does the process of developing a new drug or therapy look like in Poland? Collaboration between science and business – what works and what needs improvement The Polish biotech scene – potential, barriers, and successes 💡 This conversation is for everyone interested in modern medicine, innovation, and the real impact of science on patients' lives. 📌 Subscribe so you don't miss out on future conversations about innovation and technology! Follow us on: Facebook ➡️ www.facebook.com/MamBiznes LinkedIn ➡️ www.linkedin.com/company/mambiznes/ Website ➡️ www.mambiznes.pl Email ➡️ [email protected] Bankier.pl is a partner of the first series of the Startup Talks podcast. Join us! 00:00:00 Intro 00:02:37 Will medical biotechnology become a showcase for Polish innovation? English: 00:11:00 Poland's position in the global biotechnology sector 00:14:44 The development process of a new drug or therapy in Poland 00:26:05 Availability of clinical trials on the Polish market 00:28:57 Drug registration - regulatory standards 00:31:59 Cooperation between science and business 00:37:22 What diseases are we looking for drugs for? 00:38:53 Polish biotechnology successes 00:42:08 Trends in medical biotechnology